CCND2 amplification is an independent adverse prognostic factor in IDH-mutant lower-grade astrocytoma

Timothy E. Richardson; Jamie M. Walker

doi:10.5414/NP301354

CCND2 amplification is an independent adverse prognostic factor in IDH-mutant lower-grade astrocytoma

Timothy E. Richardson, Jamie M. Walker

Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	209-214
Number of pages	6
Journal	Clinical Neuropathology
Volume	40
Issue number	7
DOIs	https://doi.org/10.5414/NP301354
State	Published - Aug 2021

ASJC Scopus subject areas

Pathology and Forensic Medicine
Neurology
Clinical Neurology

Access to Document

10.5414/NP301354

Cite this

@article{b2d806c22ce644c4804063db89b1801e,

title = "CCND2 amplification is an independent adverse prognostic factor in IDH-mutant lower-grade astrocytoma",

author = "Richardson, {Timothy E.} and Walker, {Jamie M.}",

year = "2021",

month = aug,

doi = "10.5414/NP301354",

language = "English (US)",

volume = "40",

pages = "209--214",

journal = "Clinical Neuropathology",

issn = "0722-5091",

publisher = "Dustri-Verlag Dr. Karl Feistle",

number = "7",

}

TY - JOUR

T1 - CCND2 amplification is an independent adverse prognostic factor in IDH-mutant lower-grade astrocytoma

AU - Richardson, Timothy E.

AU - Walker, Jamie M.

PY - 2021/8

Y1 - 2021/8

UR - http://www.scopus.com/inward/record.url?scp=85108386182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85108386182&partnerID=8YFLogxK

U2 - 10.5414/NP301354

DO - 10.5414/NP301354

M3 - Letter

C2 - 33560216

AN - SCOPUS:85108386182

SN - 0722-5091

VL - 40

SP - 209

EP - 214

JO - Clinical Neuropathology

JF - Clinical Neuropathology

IS - 7

ER -

CCND2 amplification is an independent adverse prognostic factor in IDH-mutant lower-grade astrocytoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this